1. Home
  2. ITRN vs RGNX Comparison

ITRN vs RGNX Comparison

Compare ITRN & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ituran Location and Control Ltd.

ITRN

Ituran Location and Control Ltd.

N/A

Current Price

$47.45

Market Cap

881.7M

Sector

Technology

ML Signal

N/A

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

N/A

Current Price

$8.50

Market Cap

761.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ITRN
RGNX
Founded
1994
2008
Country
Israel
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
881.7M
761.9M
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
ITRN
RGNX
Price
$47.45
$8.50
Analyst Decision
Buy
Strong Buy
Analyst Count
1
8
Target Price
$50.00
$29.13
AVG Volume (30 Days)
65.0K
994.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
4.21%
N/A
EPS Growth
N/A
23.75
EPS
N/A
N/A
Revenue
N/A
$10,393,000.00
Revenue This Year
$9.12
$127.88
Revenue Next Year
$10.70
$42.53
P/E Ratio
$16.85
N/A
Revenue Growth
N/A
126.48
52 Week Low
$30.23
$5.04
52 Week High
$49.72
$16.19

Technical Indicators

Market Signals
Indicator
ITRN
RGNX
Relative Strength Index (RSI) 54.44 34.09
Support Level $35.09 $7.67
Resistance Level N/A $9.28
Average True Range (ATR) 1.38 0.58
MACD -0.09 0.07
Stochastic Oscillator 46.31 22.46

Price Performance

Historical Comparison
ITRN
RGNX

About ITRN Ituran Location and Control Ltd.

Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services and Telematics products. The Telematics services segment consists of regionally-based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others. The company derives maximum revenue from Israel.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Share on Social Networks: